Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 33226 - 33250 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Calcitriol	Approved Investigational Nutraceutical	EPPK1	83481	upregulated	Calcitriol results in increased expression of EPPK1 mRNA	8q24.3	A22299
Calcitriol	Approved Investigational Nutraceutical	EPS8L1	54869	upregulated	Calcitriol results in increased expression of EPS8L1 mRNA	19q13.42	A22301
Calcitriol	Approved Investigational Nutraceutical	EPSTI1	94240	downregulated	Calcitriol results in decreased expression of EPSTI1 mRNA	13q14.11	A22299
Calcitriol	Approved Investigational Nutraceutical	ERBB3	2065	upregulated	Calcitriol results in increased expression of ERBB3 mRNA	12q13.2	A22299
Calcitriol	Approved Investigational Nutraceutical	ERCC6L	54821	downregulated	Calcitriol results in decreased expression of ERCC6L mRNA	Xq13.1	A22301
Calcitriol	Approved Investigational Nutraceutical	ERMP1	79956	upregulated	Calcitriol results in increased expression of ERMP1 mRNA	9p24.1	A22300 A22299
Calcitriol	Approved Investigational Nutraceutical	ERO1A	30001	upregulated	Calcitriol results in increased expression of ERO1A mRNA	14q22.1	A22301
Calcitriol	Approved Investigational Nutraceutical	ERRFI1	54206	upregulated	Calcitriol results in increased expression of ERRFI1 mRNA	1p36.23	A22301
Calcitriol	Approved Investigational Nutraceutical	ESCO2	157570	downregulated	Calcitriol results in decreased expression of ESCO2 mRNA	8p21.1	A22301
Calcitriol	Approved Investigational Nutraceutical	ESPL1	9700	downregulated	Calcitriol results in decreased expression of ESPL1 mRNA	12q13.13	A22301
Calcitriol	Approved Investigational Nutraceutical	ESR1	2099	upregulated	Calcitriol results in increased expression of ESR1 mRNA	6q25.1-q25.2	A22300 A22299
Calcitriol	Approved Investigational Nutraceutical	ESRP1	54845	upregulated	Calcitriol results in increased expression of ESRP1 mRNA	8q22.1	A22299
Calcitriol	Approved Investigational Nutraceutical	ETNK2	55224	upregulated	Calcitriol results in increased expression of ETNK2 mRNA	1q32.1	A22300
Calcitriol	Approved Investigational Nutraceutical	ETS2	2114	downregulated	Calcitriol results in decreased expression of ETS2 mRNA	21q22.2	A22300
Calcitriol	Approved Investigational Nutraceutical	ETV4	2118	upregulated	Calcitriol results in increased expression of ETV4 mRNA	17q21.31	A22306
Calcitriol	Approved Investigational Nutraceutical	EVA1A	84141	downregulated	Calcitriol results in decreased expression of EVA1A mRNA	2p12	A22299
Calcitriol	Approved Investigational Nutraceutical	EVA1B	55194	upregulated	Calcitriol results in increased expression of EVA1B mRNA	1p34.3	A22301
Calcitriol	Approved Investigational Nutraceutical	EVC	2121	downregulated	Calcitriol results in decreased expression of EVC mRNA	4p16.2	A22301
Calcitriol	Approved Investigational Nutraceutical	EVI2A	2123	downregulated	Calcitriol results in decreased expression of EVI2A mRNA	17q11.2	A22299
Calcitriol	Approved Investigational Nutraceutical	EVI2B	2124	upregulated	Calcitriol results in increased expression of EVI2B mRNA	17q11.2	A22303
Calcitriol	Approved Investigational Nutraceutical	EVI5	7813	upregulated	Calcitriol results in increased expression of EVI5 mRNA	1p22.1	A22300
Calcitriol	Approved Investigational Nutraceutical	EVPL	2125	upregulated	Calcitriol results in increased expression of EVPL mRNA	17q25.1	A22299
Calcitriol	Approved Investigational Nutraceutical	EXO1	9156	downregulated	Calcitriol results in decreased expression of EXO1 mRNA	1q43	A22301
Calcitriol	Approved Investigational Nutraceutical	EXO5	64789	downregulated	Calcitriol results in decreased expression of EXO5 mRNA	1p34.2	A22301
Calcitriol	Approved Investigational Nutraceutical	EXOSC2	23404	downregulated	Calcitriol results in decreased expression of EXOSC2 mRNA	9q34.12	A22301

Displaying entries 33226 - 33250 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability